Whereas a reduction from 24 mg to 20 mg was associated with a drop in Tg levels or RECIST measurements in 3/4 cases, a reduction from 20 mg to 14 mg translated to intermittent increases in serum tumor marker values in 3/5 patients (without changes in RECIST in any of the patients). The gene discussed is TG; the disease is neoplasm.